Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease
- 1 March 1990
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 110 (1-2) , 216-220
- https://doi.org/10.1016/0304-3940(90)90814-p
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Molecular genetic approaches to Alzheimer's diseaseTrends in Neurosciences, 1989
- XENOBIOTIC METABOLISM IN MOTORNEURON DISEASEThe Lancet, 1988
- INCREASED NIGRAL IRON CONTENT IN POSTMORTEM PARKINSONIAN BRAINThe Lancet, 1987
- Abnormal glutamate metabolism in amyotrophic lateral sclerosisAnnals of Neurology, 1987
- LIPID PEROXIDATION AS CAUSE OF NIGRAL CELL DEATH IN PARKINSON'S DISEASEThe Lancet, 1986
- BIOCHEMISTRY OF SULFUR-CONTAINING AMINO ACIDSAnnual Review of Biochemistry, 1983
- Serum concentration of inorganic sulfate in mammals: Species differences and circadian rhythmComparative Biochemistry and Physiology Part A: Physiology, 1980
- Free amino acid levels in amyotrophic lateral sclerosisAnnals of Neurology, 1978
- The inhibition of mouse brain glutamate decarboxylase by some structural analogues of L-glutamic acidBiochemical Pharmacology, 1977
- Amino acid abnormalities in cerebrospinal fluid of patients with parkinsonism and extrapyramidal disordersNeurology, 1976